메뉴 건너뛰기




Volumn 28, Issue 17, 2007, Pages 2172-2173

Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial [2]

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 34948877514     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm257     Document Type: Letter
Times cited : (16)

References (6)
  • 6
    • 0034633819 scopus 로고    scopus 로고
    • Topol EJ, Ohman EM, Armstrong PW, Wilcox R, Skene AM, Aylward P, Simes J, Dalby A, Betriu A, Bode C, White HD, Hochman JS, Emanuelson H, Vahanian A, Sapp S, Stebbins A, Moliterno DJ, Califf RM, on Behalf of the GUSTO-III Investigators*. Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction. Results from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) III trial. Circulation 2000;102:1761-1765.
    • Topol EJ, Ohman EM, Armstrong PW, Wilcox R, Skene AM, Aylward P, Simes J, Dalby A, Betriu A, Bode C, White HD, Hochman JS, Emanuelson H, Vahanian A, Sapp S, Stebbins A, Moliterno DJ, Califf RM, on Behalf of the GUSTO-III Investigators*. Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction. Results from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) III trial. Circulation 2000;102:1761-1765.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.